Journal of Respiratory Medicine
Open Access

Sleep-disordered breathing; Obstructive sleep apnea; Central sleep apnea; Complex sleep apnea syndrome; Hypopnea; Apnea-hypopnea index; Polysomnography; Positive airway pressure therapy

Introduction

Sleep-disordered breathing (SDB) encompasses a range of breathing difficulties during sleep, from mild snoring to severe obstructive sleep apnea (OSA). It affects millions of people worldwide, impacting their quality of life and overall health. Understanding the causes, symptoms, and treatment options for SDB is crucial for both sufferers and healthcare providers. Sleep-disordered breathing (SDB) encompasses a spectrum of disorders characterized by abnormalities in breathing during sleep, ranging from mild snoring to severe obstructive sleep apnea (OSA). It constitutes a significant public health concern, affecting individuals of all ages and demographics worldwide [1]. The intricate interplay between respiratory physiology and sleep architecture underscores the complexity of these conditions, which can have far-reaching implications for overall health and well-being. At the core of SDB lies the disruption of normal breathing patterns during sleep. While occasional snoring is common and often benign, persistent and loud snoring may signal underlying airway obstruction. This obstruction can lead to intermittent cessations in breathing, known as apneas, or significant reductions in airflow, termed hypopneas. These events can fragment sleep, disrupt normal sleep architecture, and result in oxygen desaturation, arousals from sleep, and increased sympathetic nervous system activity, all of which contribute to a myriad of adverse health consequences. Obstructive sleep apnea (OSA), the most prevalent form of SDB, is characterized by recurrent episodes of partial or complete upper airway obstruction during sleep, leading to airflow limitation or cessation. The collapse of the upper airway can be attributed to various factors, including anatomical predispositions such as obesity, craniofacial abnormalities, or enlarged tonsils, as well as functional factors such as decreased muscle tone during sleep. Central sleep apnea (CSA) represents a distinct subtype of SDB, characterized by a lack of respiratory effort due to altered central respiratory control mechanisms. Complex sleep apnea syndrome (CompSAS), a relatively newly recognized entity, involves a combination of obstructive and central apneas in the same individual [2]. In light of the substantial morbidity and mortality associated with SDB, early recognition and appropriate management are paramount. Diagnostic evaluation typically involves comprehensive sleep assessment, including clinical history, physical examination, and objective sleep studies such as polysomnography (PSG) or home sleep apnea testing (HSAT). Treatment strategies for SDB encompass a broad array of modalities, ranging from lifestyle modifications and positional therapy to positive airway pressure (PAP) therapy, oral appliances, and surgical interventions. The selection of treatment modality depends on various factors, including disease severity, patient preferences, comorbidities, and treatment efficacy.

Sleep-disordered breathing represents a heterogeneous group of disorders characterized by abnormalities in breathing during sleep, with obstructive sleep apnea constituting the most prevalent form. Untreated SDB is associated with a multitude of adverse health outcomes, including cardiovascular disease, metabolic dysfunction,neurocognitive impairment, and diminished quality of life. Therefore, prompt recognition, accurate diagnosis, and effective management of SDB are essential to mitigate its detrimental effects and improve overall health outcomes [3].

Causes

SDB can result from various factors, including anatomical abnormalities, lifestyle choices, and medical conditions. One common cause is the relaxation of muscles in the throat during sleep, leading to airway obstruction. This obstruction can be partial, causing snoring, or complete, resulting in apnea episodes. Factors such as obesity, smoking, alcohol consumption, and certain medications can exacerbate SDB symptoms.

Symptoms

The symptoms of SDB can vary in severity and may include:

Snoring: Loud, persistent snoring is a hallmark symptom of SDB, particularly OSA [4].

Daytime sleepiness: Individuals with SDB often experience excessive daytime sleepiness due to disrupted sleep patterns.

Gasping or choking during sleep: Sudden awakenings accompanied by gasping or choking sensations are common in OSA.

Morning headaches: Waking up with headaches can be a sign of oxygen deprivation during sleep.

Poor concentration and memory: Sleep fragmentation caused by SDB can impair cognitive function and memory.

Irritability and mood swings: Chronic sleep deprivation due to SDB can lead to mood disturbances [5].

Diagnosis

Diagnosing SDB typically involves a combination of medical history evaluation, physical examination, and sleep studies. Polysomnography (PSG) is the gold standard for diagnosing SDB, as it monitors various physiological parameters during sleep, including airflow, oxygen levels, and brain activity [6]. Home sleep apnea tests (HSATs) may also be used for screening purposes, particularly in cases of suspected OSA.

Treatment

Treatment options for SDB aim to alleviate symptoms, improve sleep quality, and reduce associated health risks. The appropriate treatment depends on the severity and underlying cause of the condition. Common interventions include:

Continuous Positive Airway Pressure (CPAP) therapy: CPAP is the primary treatment for moderate to severe OSA. It involves wearing a mask connected to a machine that delivers pressurized air to keep the airway open during sleep [7].

Oral appliances: Dental devices such as mandibular advancement devices (MADs) and tongue-retaining devices (TRDs) can help alleviate mild to moderate OSA by repositioning the jaw or tongue to prevent airway collapse.

Lifestyle modifications: Weight loss, smoking cessation, avoiding alcohol and sedatives before bedtime, and sleeping on your side instead of your back can help reduce SDB symptoms [8].

Surgery: Surgical interventions such as uvulopalatopharyngoplasty (UPPP), tonsillectomy, and maxillomandibular advancement (MMA) may be recommended in cases where anatomical abnormalities contribute to SDB.

Positional therapy: For individuals with positional OSA, devices or techniques that encourage sleeping in a non-supine position can be beneficial [9].

Complications

Untreated SDB can lead to various complications, including hypertension, cardiovascular disease, stroke, diabetes, and impaired daytime functioning. It can also increase the risk of accidents, particularly while driving or operating machinery due to excessive daytime sleepiness [10].

Conclusion

Sleep-disordered breathing is a common yet potentially serious condition that affects millions of people worldwide. Early diagnosis and appropriate treatment are essential for improving sleep quality, reducing associated health risks, and enhancing overall well-being. By understanding the causes, symptoms, and treatment options for SDB, individuals can take proactive steps to manage their condition and improve their quality of life. Sleep-disordered breathing encompasses a spectrum of disorders ranging from snoring to obstructive sleep apnea (OSA), each posing significant health risks and impacting quality of life. As we delve into its implications, it becomes evident that sleepdisordered breathing is not merely a nocturnal inconvenience but a multifaceted condition with far-reaching consequences.

Firstly, the physiological ramifications of sleep-disordered breathing are profound. OSA, characterized by recurrent upper airway collapse during sleep, leads to intermittent hypoxemia, fragmented sleep, and increased sympathetic activity. These disruptions manifest in daytime symptoms such as excessive daytime sleepiness, impaired cognitive function, and mood disturbances. Moreover, the chronic oxygen desaturation and sympathetic overactivity associated with OSA contribute to a myriad of cardiovascular complications, including hypertension, coronary artery disease, stroke, and arrhythmias. Thus, the cardiovascular system bears a substantial burden in the context of sleep-disordered breathing. Sleep-disordered breathing transcends its nocturnal manifestations, exerting a pervasive influence on physical, mental, and socioeconomic well-being. Recognizing its significance necessitates a comprehensive approach encompassing early detection, multidisciplinary management, and public health initiatives aimed at raising awareness and improving access to care. By prioritizing sleep health and addressing sleep-disordered breathing, we can mitigate its far-reaching consequences, enhance quality of life, and promote overall health and well-being.

References

1. Bidaisee S, Macpherson CN (2014) Zoonoses and one health: a review of the literature. J Parasitol 2014:1-8.

Indexed at, Google Scholar, Crossref

2. Cooper GS, Parks CG (2004) Occupational and environmental exposures as risk factors for systemic lupus erythematosus. Curr Rheumatol Rep 6: 367-374.

Indexed at, Google Scholar, Crossref

3. Parks CG, Santos AS, Barbhaiya M, Costenbader KH (2017) Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 31: 306-320.

Indexed at, Google Scholar, Crossref

4. Barbhaiya M, Costenbader KH (2016) Environmental exposures and the development of systemic lupus erythematosus. Curr Opin Rheumatol 28: 497-505.

Indexed at, Google Scholar, Crossref

5. Cohen SP, Mao J (2014) Neuropathic pain: mechanisms and their clinical implications. BMJ 348: 1-6.

Indexed at, Google Scholar, Crossref

6. Mello RD, Dickenson AH (2008) Spinal cord mechanisms of pain. BJA 101: 8-16.

Indexed at, Google Scholar, Crossref

7. Bliddal H, Rosetzsky A, Schlichting P, Weidner MS, Andersen LA, et al. (2000) A randomized, placebo-controlled, cross-over study of ginger extracts and ibuprofen in osteoarthritis. Osteoarthr Cartil 8: 9-12.

Indexed at, Google Scholar, Crossref

8. Maroon JC, Bost JW, Borden MK, Lorenz KM, Ross NA, et al. (2006) Natural anti-inflammatory agents for pain relief in athletes. Neurosurg Focus 21: 1-13.

Indexed at, Google Scholar, Crossref

9. Birnesser H, Oberbaum M, Klein P, Weiser M (2004) The Homeopathic Preparation Traumeel® S Compared With NSAIDs For Symptomatic Treatment Of Epicondylitis. J Musculoskelet Res 8: 119-128.

Indexed at, Google Scholar, Crossref

10. Gergianaki I, Bortoluzzi A, Bertsias G (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 32: 188-205.

Indexed at, Google Scholar, Crossref